FindTrial
Sign In

Multi omics analysis of the occurrence and evolution of immune responses before and after kidney transplantation

Multi omics analysis of the occurrence and evolution of immune responses before and after kidney transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122892
Enrollment
Unknown
Registered
2026-04-20
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney transplant

Interventions

Post renal transplant rejection infection group:None
Infection only group after kidney transplantation:None
Normal group after kidney transplantation:None
Only rejection group after kidney transplantation:None

Sponsors

The Second Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age range: 18-65 years old, receiving a solid organ transplant (kidney) for the first time; 2. Relevant inspection materials and the ability to collect complete samples.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Those with critical medical conditions and difficulty in accurately evaluating the effectiveness and safety of treatment; 3. Non renal transplant surgery; 4. Other combined transplantation surgeries.

Design outcomes

Primary

MeasureTime frame
Differential molecules and metabolic pathways;—

Countries

China

Contacts

Public ContactYingting Huang

The Second Affiliated Hospital of Guangxi Medical University

huangyt_gxmu@163.com+86 771 327 7169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026